drugset / Trial / NCT02169414
Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effect of BIA 9 1067 (5 mg, 15 mg and 50 mg) in steady-state conditions on the levodopa pharmacokinetics of a single dose of immediate-release levodopa/carbidopa 100/25 mg and of a single dose of immediate-release levodopa/benserazide 100/25 mg.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 5 mg | — |
| Subject | Opicapone | Small molecule | 15 mg | — |
| Subject | Opicapone | Small molecule | 50 mg | — |
| Subject | levodopa/benserazide | Unknown | — | — |
| Subject | levodopa/carbidopa | Unknown | — | — |